Trademark Alertz ®
Search
Trademark
Owner
Trademark: PLUS THERAPEUTICS 2081900
Word
PLUS THERAPEUTICS
Device Descrption:
PLUS SIGN IS PART OF LTR P
ID
2081900
Trademark Type
Figurative
Status
Protected: Registered/protected
Application Date
11 December 2019
Registration Date
11 December 2019
Renewal Date
11 December 2029
Owner(s)
PLUS THERAPEUTICS, INC.
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 5
:
Nanomedicinal products for medical purposes, namely organic and inorganic pharmaceutical preparations, nanoparticle pharmaceutical preparations, nutraceuticals, pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the central nervous system, oncological diseases and disorders, and ophthalmological diseases and disorders
;
chemical preparations and reagents for pharmaceutical, medical, and clinical purposes
;
drug delivery agents in the form of nanoparticle powders that facilitate the delivery of pharmaceutical preparations
;
liposomal nanoparticle powders being drug delivery agents to facilitate delivery of genetic material and vaccines for medical purposes
;
all of the aforementioned for human or animal use.
Class 40
:
Providing technical information in the field of pharmaceutical manufacturing
;
custom manufacture of pharmaceuticals
;
providing information about custom manufacturing of pharmaceuticals in the nature of oral, inhalatory, intramuscular, intraperitoneal, intratracheal, intratumoral, intravenous, subcutaneous, and topical applied aggregations of liposomes providing time-release of encapsulated pharmaceuticals made to the order or specification of others, for treatment of a wide variety of diseases
;
custom manufacturing of pharmaceuticals in the nature of oral, inhalatory, intramuscular, intraperitoneal, intratracheal, intratumoral, intravenous, subcutaneous, and topical applied aggregations of liposomes providing time-release of encapsulated pharmaceuticals made to the order or specification of others, for treatment of a wide variety of diseases.
Class 42
:
Drug discovery services
;
pharmaceutical research and development
;
research and development of nanomedicinal products
;
scientific and medical research and development for nutraceuticals, pharmaceuticals, pharmaceutical preparations and substances in the field of cancer, diabetes, infectious diseases, autoimmune diseases and disorders, orthopedic diseases and disorders, blood diseases and disorders, fungal infections, diseases and disorders of the central nervous system, oncological diseases and disorders, and ophthalmological diseases and disorders
;
scientific research and development for pharmaceuticals in the nature of oral, inhalatory, intramuscular, intraperitoneal, intratracheal, intratumoral intravenous, subcutaneous, and topical applied aggregations of liposomes providing time-release of encapsulated pharmaceuticals, for treatment of a wide variety of diseases
;
providing medical and scientific information in the aforementioned fields.
Class 44
:
Medical services, namely, administration of nanomedicinal medications
;
medical services, namely, medical consultancy relating to nanomedicinal products.